Lecture 8: Depression Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

at least 1 of the symtpoms of major depressive disorder (MDD)

A
  • depressed mood
  • loss of interest or pleasure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

other symptoms of MDD

A
  • weight loss or weight gain
  • increase/decrease in appetite
  • insomnia or hypersomnia
  • psychomotor agitation or delay
  • fatigue or loss of energy
  • feelings of worthlessness or guilt
  • reduced ability to think or concentrate
  • recurring thoughts of death, suicidal thoughts, or plan/attempt
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

prevalence

A

refers to the number of people with the disorder at a given time or during a given period
- depression is more prevalent in women (diagnosed 1.7 times more often than men)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how many people have mood disorders

A
  • UK: 4 million +
  • Europe: 33 million +
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

recovery from MDD

A
  • 54% of patients are likely to recover within 6 months
  • 81% within 2 years
  • relapse is highly likely (58% relapse within the next 10 years)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

depressive symptoms

A

different from depressive disorder
- may be transient and occur in response to stressful life events without developing into a depressive disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

unipolar depression

A

a purely depressive disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

bipolar depression

A

bipolar patients have depression that alternates with periods of mania

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

bipolar I vs bipolar II

A
  • bipolar I is the classic manic depression
  • bipolar II is a milder variant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

symptoms of a manic episode

A
  • inflated sense of self-worth or grandeur
  • decrease in need for sleep
  • more talkative than usual or feels pressure to keep talking
  • lost of ideas or feeling like thoughts are racing
  • quickly distracted
  • increased in purposeful activity or psychomotor agitation
  • increased involvement in activities that are highly likely to produce pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

hypomania

A

a marked period of abnormally and persistently elevated, expansive, or irritable mood and increased goal-directed activity or energy
- lasting at least 4 days and present most of the day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

endogenous depression

A

occurs for no apparent reason
- potentially caused by an underlying neurochemical imbalance as the critical neuropathology
- tends to respond well to pharmacotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

reactive depression

A

can be seen as a result of a stressful life event
- responds better to psychological interventions (e.g. cognitive-behavioral therapy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

factors which can cause depression

A
  • family history
  • abuse
  • trauma and stress
  • death or loss
  • pessimistic personality
  • major life events
  • physical conditions
  • social isolation
  • lack of exposure to sunlight
  • hormones
  • other mental disorders
  • drug abuse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

twin studies of depression

A

estimate the heritability of depression in monozygotic twins at 40/50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

equifinality

A

the idea that multiple different causes or processes (e.g. genetic, environmental, or psychological factors) can lead to the same outcome, such as the development of depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

effect of the hypothalamic-pituitary-adrenal axis (HPA) for depression

A

norepinephrine, acetylcholine, serotonin, and GABA are mobilized in response to stress
- activates cortisol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

stress diathesis model of depression

A

integrates environmental experiences (e.g. stressors), with genetic predisposition (diathesis)

19
Q

stress theory of depression

A

emphasizes the role of a dysregulated HPA axis in depression

20
Q

noradrenergic hypothesis

A

depression results from reduced norepinephrine (noradrenaline) activity

21
Q

reserpine

A

a drug that depletes norepinephrine in the brain
- depletion leads to depressive symptoms that can be reversed by antidepressants

22
Q

amphetamine

A

increases norepinephrine levels and produces a euphoric high
- increases monoamine levels

23
Q

monoamine oxidase inhibitors (MAOIs)

A

among the first successful treatments for depression
- block the action of MAO, an enzyme that breaks down norepinephrine and other neurotransmitters
- increases availability of norepinephrine at the synapses

24
Q

tricyclic antidepressants (TCAs)

A

work by inhibiting the reuptake of serotonin and norpinephrine into the presynaptic neuron
- increases the concentration of norepinephrine in the synapse, allowing it to exert its effects for a longer period of time
- tend to have more side effects than other types of antidepressants (dry mouth, blurred vision, constipation, and sedation)

25
Q

alpha-2 autoreceptors

A

are on the presynaptic neurons and inhibit norepinephrine release when activated
- acted upon by drugs such as clonidine
- chronic use of antidepressants block these autoreceptors, reducing their inhibitory effect

26
Q

serotonin hypothesis

A

proposes that low serotonin levels contribute to depression
- serotonin is critical for mood regulation

27
Q

selective serotonin reuptake inhibitors (SSRIs)

A

work by preventing the reuptake of serotonin, thereby increasing its availability at the synapse
- e.g. fluoxetine (Prozac) and sertaline (Zoloft)
- relatively low side effects compared to TCAs
- may cause gastrointestinal disturbances or sleep issues

28
Q

inflammation theory

A

suggests that elevated levels of pro-inflammatory cytokines are associated with depression
- inflammation in the brain can cause symptoms that resemble sickness behavior (fatigue, social withdrawal, loss of appetite)

29
Q

neuroplasticity theory

A

links depression to reduced neuroplasticity (brain’s ability to adapts and reorganize
- in depression, levels of brain-derived neurotrophic factor (BDNF), a key protein involved in neuroplasticity, are lower

30
Q

atypical antidepressants

A

include a variety of drugs that do not fit into other categories but are still effective in treating depression
- may target different neurotransmitter systems such as norepinephrine and dopamine (e.g. Bupropion)

31
Q

selective norepinephrine reuptake inhibitors (SNRIs)

A

inhibit reuptake of both serotonin and norepinephrine
- used to treat depression, anxiety, and chronic pain
- e.g. venlafaxine (Effexor)

32
Q

dual-action antidepressants

A

drugs that target both the serotonin and norepinephrine systems to increase their availability
- may include atypical antidepressants and SNRIs, targeting multiple neurotransmitter pathways to address symptoms of depression

33
Q

lithium

A

primarily used in the treatment of bipolar disorder, particularly in management of manic episodes
- effective in reducing the frequency and severity of mania, but also used in combination with other antidepressants to treat the depressive phase
- increases serotonin and stabilizes mood through several mechanisms

34
Q

electroconvulsive therapy (ECT)

A

a treatment for severe depression that has not responsed to other treatments
- involves inducing seizures through electrical stimulation of the brain
- can be very effective in treatment-resistant depression and severe cases

35
Q

psychotherapy

A

cognitive behavioral therapy (CBT) and other therapeutic interventions are often used to treat depression
- helps patients identify and change negative thought patterns and behaviors that contribute to their depression

36
Q

vagus nerve stimulaiton (VNS)

A

the stimulation of the vagus nerve with electrical impulses
- typically delivered through an implanted device
- used for treatment-resistant depression and has shown promise in reducing symptoms in some patients

37
Q

light therapy

A

often used to treat seasonal affective disorder (SAD)
- patients are exposed to bright artificial light
- helps regulate mood by affecting the production of melatonin and serotonin

38
Q

St. John’s wort (hypericum perforatum)

A

a herbal remedy often used as an alternative treatment for mild to moderate cases of depression
- thought to work by increasing serotonin levels
- still under debate

39
Q

depression and co-occuring somatic disorders

A

depression is often associated with somatic illnesses (40-60% of depressed patients
- can reduce effectiveness of medical treatments
- 85% of patients with mild and 60% of patients with severe depression go unrecognized by primary care physicians (complaints are often not taken seriously leading to inadequate care)

40
Q

psychosocial aspects to somatic conditions

A

patients deal with loss, trauma, limitations in self-care, work, and social or family life
- unpredictability of certain illnesses can increase likelihood of depression

41
Q

psychobiological aspects to somatic conditions

A

depression can result from neurological damage, hormonal imbalances, or as a side effect of certain medications

42
Q

conditions leading to increased risk of depression

A

conditions with eleveated cytokine levels, such as autoimmune diseases, chronic infections, obesity, diabetes mellitus, and cardiovascular disease increase the risk of depression

43
Q

medications leading to increased risk of depression

A

medications for conditions such as hypertension, hormone treatments, and drugs such as alpha-interferon are known to contribute to the onset of depression